Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$4.13 -0.15 (-3.50%)
At close: Oct 22, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Selling, General & Administrative (2013 - 2025)

Updated

Corbus Pharmaceuticals Holdings' Selling, General & Administrative was $3.56 million in Q3 2025, down 24.3% from $4.7 million a year earlier and down 10.3% from the prior quarter.

Analysis

Corbus Pharmaceuticals Holdings (CRBP) Selling, General & Administrative (2013 - 2025) Analysis & Trends

On a trailing twelve-month basis, Corbus Pharmaceuticals Holdings' Selling, General & Administrative was $15.47 million through Sep 30, 2025, down 2.1% year-over-year; for FY2024, it was $16.5 million, up 18.6% from FY2023.

  • Selling, General & Administrative shows a five-year compound annual growth rate of -6.9% (FY2019 to FY2024).
  • In earlier years, Selling, General & Administrative was $13.91 million in FY2023 (-25.6%), $18.7 million in FY2022 (-8.5%), $20.43 million in FY2021 (-28.3%) and $28.48 million in FY2020 (+20.5%).
  • The Q3 2025 figure marks the lowest quarterly Selling, General & Administrative since Q4 2023.
  • Compared with a year earlier, Selling, General & Administrative was higher in four of the last eight quarters, with growth averaging 4.1%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2024 (growth of 59.9%); the worst was Q4 2021 (a decline of 95.8%).
  • Per Business Quant data, CRBP's Selling, General & Administrative in the three quarters before Q3 2025 was $3.97 million (Q2 2025), $4.13 million (Q1 2025) and $3.82 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,158.11 Bn 1,126.70 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 636.97 Bn 556.83 Bn 17.30 Bn 6.29 Bn
3 AbbVie 501.44 Bn 474.55 Bn 12.70 Bn 3.63 Bn
4 Merck 357.35 Bn 311.73 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 301.15 Bn 265.14 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.27 Bn 238.95 Bn 12.86 Bn 5.65 Bn
7 Amgen 238.93 Bn 194.33 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.19 Bn 168.38 Bn 6.22 Bn 1.92 Bn
9 Pfizer 172.28 Bn 118.93 Bn 10.94 Bn 3.41 Bn
10 Corbus Pharmaceuticals Holdings 49.75 Mn -466.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 3.56 Mn
Jun 30, 2025 3.97 Mn
Mar 31, 2025 4.13 Mn
Dec 31, 2024 3.82 Mn
Sep 30, 2024 4.70 Mn
Jun 30, 2024 4.12 Mn
Mar 31, 2024 3.86 Mn
Dec 31, 2023 3.12 Mn
Sep 30, 2023 2.94 Mn
Jun 30, 2023 3.94 Mn
Mar 31, 2023 3.91 Mn
Dec 31, 2022 4.55 Mn
Sep 30, 2022 4.07 Mn
Jun 30, 2022 4.84 Mn
Mar 31, 2022 5.23 Mn
Dec 31, 2021 226,000.00
Sep 30, 2021 5.28 Mn
Jun 30, 2021 5.57 Mn
Mar 31, 2021 5.34 Mn
Dec 31, 2020 5.36 Mn
API Access

Corbus Pharmaceuticals Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRBP&period=max&api_key=YOUR_API_KEY